CHINESE AMERICAN HEMATOLOGIST AND … - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

LIANG DENG MD PHD

Phone

4149189890

Tax Period

2023-01-01 to 2023-12-31

CHINESE AMERICAN HEMATOLOGIST AND ONCOLOGIST NETWORK INC, founded in 2005, is a small nonprofit in the Diseases & Disorders sector that reported $825K in total revenue in fiscal year 2023. Revenue decreased 7% compared to the prior year. The organization ran a surplus of $244K, a strong 30% operating margin.

Mission

FOSTERING COMMUNICATIONS AMONG CHINESE AMERICAN MEDICAL PROFESSIONALS FOR THE DELIVERY OF HIGH-QUALITY HEALTH CARE TO PATIENTS WITH NEOPLASTIC AND HEMATOLOGICAL DISEASES, AND TO PROMOTING THE EXCHANGE OF MEDICAL INFORMATION BETWEEN THE UNITED STATES AND CHINA IN THE FIELDS OF HEMATOLOGY AND ONCOLOGY.

Program Service Accomplishments

Program 1

Expenses: $219,163 Revenue: $342,800

NEW YORK ONCOLOGY FORUM - FOCUSES ON ONCOLOGY ADVANCEMENTS IN VARIOUS DISEASE STATES SUCH AS BREAST, GASTROINTESTINAL, GENITOURINARY, GYNECOLOGICAL, HEAD & NECK, HEMATOLOGIC MALIGNACIES, SKIN CANCER...

Program 2

Expenses: $161,926 Revenue: $239,000

COMMUNITY ONCOLOGY FORUM - WITH AN EMPHASIS ON EDUCATIONAL NEEDS FOR COMMUNITY PRACTICE ONCOLOGISTS, THE PURPOSE OF THIS EVENT IS TO OFFER EXPERT PERSPECTIVES AND PRACTICAL INSIGHTS INTO THE USE OF IMMUNOTHERAPY AND TARGETED TREATMENTS IN CANCER CARE WITH FOCUSES ON HEAD AND NECK CANCER, BREAST CANCER, LYMPHOMA AND LEUKEMIA. IT ALSO SERVES TO FOSTER COLLABORATION AND PROVIDE A VIRTUAL FORUM FOR INTERACTION AND COLLABORATION BETWEEN PRACTICING HEMATOLOGIST AND ONCOLOGISTS WORKING IN THE FIELD.

Program 3

Expenses: $55,103 Revenue: $105,800

ASH DINNER FOCUSES ON CURRENT HEMATOLOGY AND ONCOLOGY ADVANCEMENTS IN TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA, ACUTE LYMPHOCYTIC LEUKEMIA, NON-HODGKIN LYMPHOMA, AND MULTIPLE MYELOMA AND FOSTERS...

ASH DINNER FOCUSES ON CURRENT HEMATOLOGY AND ONCOLOGY ADVANCEMENTS IN TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA, ACUTE LYMPHOCYTIC LEUKEMIA, NON-HODGKIN LYMPHOMA, AND MULTIPLE MYELOMA AND FOSTERS COLLABORATION AND PROVIDES A FORUM FOR INTERACTION BETWEEN PRACTICING ONCOLOGISTS AND BIOSCIENTISTS WORKING IN THE FIELD.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $36,665

Program Service Revenue $769,900

Investment Income $11,392

Other Revenue $6,967

TOTAL REVENUE $824,924

Expense Breakdown

Grants Paid $63,050

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $512,496

Other Expenses $517,522

TOTAL EXPENSES $580,572

Year-over-Year Comparison

	2023	2022	Change
Revenue	$824,924	$882,461	-0.1%
Expenses	$580,572	$635,008	-0.1%
Net Income	$244,352	$247,453	0.0%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHONG-XIAN PAN	IMMEDIATE PAST PRESIDENT	10.00	Director	$0	$0	$0
YI FENG	TREASURER	10.00	Officer Director	$0	$0	$0
WENRU SONG	IMMEDIATE PAST CHAIR	10.00	Director	$0	$0	$0
YIWU HUANG	MEMBER	2.00	Director	$0	$0	$0
JING-ZHOU HOU	CHAIR ELECT	10.00	Director	$0	$0	$0
TIHONG LI	SECRETARY	10.00	Officer Director	$0	$0	$0
YUXIA JIA	MEMBER	2.00	Director	$0	$0	$0
RUIRONG YUAN	CHAIR	10.00	Officer Director	$0	$0	$0
BO ZHAO	PRESIDENT	10.00	Officer Director	$0	$0	$0
LEI ZHENG	MEMBER	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$824,924	$580,572	$1,290,651	$244,352
2022	$882,461	$635,008	$1,238,813	$247,453
2021	$563,756	$267,886	$973,149	$295,870
2020	$299,508	$202,651	$558,134	$96,857
2019	$330,709	$259,669	$467,532	$71,040
2018	$319,736	$290,337	$365,006	$29,399

CHINESE AMERICAN HEMATOLOGIST AND ONCOLOGIST NETWORK INC